A potent drug taken once a day can cut the risk of dying from lung cancer by half, according to a new study that scientists hope signals a major breakthrough in tackling the disease.Osimertinib, consumed after surgery, reduced the risk of patients dying from a specific form of lung cancer by 51 per cent, results presented to the American Society of Clinical Oncology's (Asco) annual meeting - the world's largest cancer conference - in Chicago showed.
[
add
]
[
|
|
...
]